Parkinsonian disorders (PD), also known as Parkinsonism, are a group of neurological conditions characterized by the presence of motor and non-motor symptoms. The primary motor symptoms of PD include tremors, slowness of movement (bradykinesia) and stiffness, as well as limb shaking (rigidity). PD is a progressive disorder; over time, other non-motor symptoms such as changes in cognition, mood, and sensory functioning, may emerge. PD is the most common cause of parkinsonism. It is caused by a loss of neurons producing the neurotransmitter dopamine in a region of the brain called the substantia nigra. When dopamine-producing neurons die, an imbalance occurs in the brain’s glutamate, acetylcholine, and gamma-aminobutyric (GABA) systems. This leads to disruption to the regulation of movement and other processes in the brain, causing the Parkinsonian symptoms. Although there is no cure for PD, various treatments are available to help alleviate the symptoms or slow the progression of the condition. These treatments may include medications, surgical procedures, physical therapy, and lifestyle changes. Medications focus on restoring or substituting for dopamine. Parkinson's drugs, such as levodopa or dopamine agonists, replace lost dopamine. Additionally, drugs that act to increase the amount of available dopamine or improve its efficiency can be used. Surgical procedures like deep brain stimulation and thalamotomy attempt to alleviate symptoms by targeting parts of the brain to correct the dopamine deficiency. Physical therapy can help people with PD by improving their mobility and balance. Other lifestyle changes that may help individuals cope with PD and its symptoms include exercise, diet modification, and stress reduction. Overall, PD is a complex and devastating condition that affects a person's ability to move and affects their day to day life. However, with the right combination of treatments, an individual with PD can live a full and meaningful life.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States